Timothy Edwin Kelly Praxis Precision Medicines, Inc. (PRAX) insider trading activity
Timothy Edwin Kelly is Chief Financial Officer of Praxis Precision Medicines, Inc.. Currently has a direct ownership of 12,140 shares of PRAX, which is worth approximately $849,678. The most recent transaction as insider was on Jul 29, 2024, when has been sold 7,800 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
12.1K
0%
3M change
79.1%
12M change
Total Value Held
$849,678
Timothy Edwin Kelly Transaction History
TEK
Timothy Edwin Kelly
Chief Financial Officer
Cambridge, MA